![Michael Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Yang
Director/Miembro de la Junta en PACIRA BIOSCIENCES, INC. .
Fortuna: 557 548 $ al 30/06/2025
Perfil
Michael J.
Yang currently works at Ionis Pharmaceuticals, Inc., as Independent Director from 2023, Pacira Biosciences, Inc., as Independent Director from 2023, and ARTIS Ventures Management LP, as Operating Partner.
Mr. Yang also formerly worked at ViaCyte, Inc., as President, Chief Executive Officer & Director from 2021 to 2022, Akcea Therapeutics, Inc., as Director in 2020, Johnson & Johnson, as President, ACADIA Pharmaceuticals, Inc., as Chief Commercial Officer & Executive VP from 2017 to 2021, Ortho Biotech, Inc., as Vice President-Sales & Marketing, Veridex LLC, as General Manager, Therakos, Inc., as General Manager, Janssen Biotech, Inc., as President, and Janssen Pharmaceuticals, Inc., as President-Immunology from 2013 to 2017.
Mr. Yang received his undergraduate degree from San Diego State University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
PACIRA BIOSCIENCES, INC. 0,03 % | 11/06/2025 | 13.393 ( 0,03 % ) | 320 093 $ | 30/06/2025 |
| 15/07/2025 | 6.010 ( 0 % ) | 237 455 $ | 30/06/2025 |
Últimas noticias acerca de Michael Yang
Cargos activos de Michael Yang
| Empresas | Cargo | Inicio |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Director/Miembro de la Junta | 10/10/2023 |
| IONIS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 14/12/2023 |
ARTIS Ventures Management LP
 ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures Management LP (Artis Ventures) is a venture capital firm founded in 2002 by Mike Harden and Stuart L.Peterson. The firm is headquartered in San Francisco, California. | Inversor de Capital Privado | - |
Antiguos cargos conocidos de Michael Yang.
| Empresas | Cargo | Fin |
|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Director Ejecutivo | 01/10/2022 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | 29/01/2021 |
| AKCEA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/12/2020 |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | 01/03/2017 |
| JOHNSON & JOHNSON | Presidente | - |
Formación de Michael Yang.
San Diego State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| PACIRA BIOSCIENCES, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 8 |
|---|---|
Janssen Biotech, Inc.
 Janssen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA. | Health Technology |
Veridex LLC
 Veridex LLC Medical SpecialtiesHealth Technology Part of Kenvue, Inc., Veridex LLC is a company that supplies vitro diagnostic oncology products. The company is based in Raritan, NJ. | Health Technology |
Therakos, Inc.
 Therakos, Inc. BiotechnologyHealth Technology Therakos, Inc. develops immune cell therapies delivered through extracorporeal photopheresis. The firm’s engineers, clinicians and biological researchers have been driven to discover new technologies and therapeutic applications that empower the immune response and improve patient outcomes. It supports clinicians by providing products and training to enhance the treatment of cutaneous T-cell lymphoma (CTCL) and by pursuing additional approved indications for autologous immune cell therapy. The company was founded in 1984 and is headquartered in West Chester, PA. | Health Technology |
Ortho Biotech, Inc. | |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
ARTIS Ventures Management LP
ARTIS Ventures Management LP Investment ManagersFinance ARTIS Ventures Management LP (Artis Ventures) is a venture capital firm founded in 2002 by Mike Harden and Stuart L.Peterson. The firm is headquartered in San Francisco, California. | Finance |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Yang
